Prof Michel Delforge - Catholic University, Leuven, Belgium
Prof Delforge discusses giving bortezomib (Velcade) once a week and subcutaneously rather than intravenously. This is important to better manage toxicities especially in elderly patients. Talking at the International Myeloma Workshop, Paris, 5th May 2011.